31 83

Cited 0 times in

An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)

DC Field Value Language
dc.contributor.authorAhn, MJ-
dc.contributor.authorCho, JH-
dc.contributor.authorSun, JM-
dc.contributor.authorLee, SH-
dc.contributor.authorAhn, JS-
dc.contributor.authorPark, K-
dc.contributor.authorPark, KU-
dc.contributor.authorKang, EJ-
dc.contributor.authorChoi, YH-
dc.contributor.authorKim, KH-
dc.contributor.authorAn, HJ-
dc.contributor.authorLee, HW-
dc.date.accessioned2020-08-20T00:04:49Z-
dc.date.available2020-08-20T00:04:49Z-
dc.date.issued2018-
dc.identifier.issn0732183X-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/18650-
dc.language.isoen-
dc.titleAn open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09)-
dc.typeArticle-
dc.contributor.affiliatedAuthor이, 현우-
dc.type.localJournal Papers-
dc.identifier.doi10.1200/JCO.2018.36.15_suppl.9050-
dc.citation.titleJournal of clinical oncology : official journal of the American Society of Clinical Oncology-
dc.citation.volume36-
dc.citation.number15S-
dc.citation.date2018-
dc.citation.startPage9050-
dc.citation.endPage9050-
dc.identifier.bibliographicCitationJournal of clinical oncology : official journal of the American Society of Clinical Oncology, 36(15S):9050-9050, 2018-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn15277755-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
10.1200_JCO.2018.36.15_suppl.9050.pdfDownload

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse